Aureka Biotech Lands $100M Series B to Build AI-Powered Biological World Model
Aureka Biotechnologies raised $100M to advance its foundational AI models that could transform drug discovery from a trial-and-error process into a predictive science. The funding will enhance a closed-loop system integrating AI models with high-throughput lab experiments, potentially slashing the time and cost of bringing new therapies to market.